VAERS Explorer
Back to explore

Report #2867290

Received Oct 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLUBLOK)SANOFI PASTEURUNK—OT

Symptoms (2)

No adverse eventUnderdose

Symptom narrative

patient not receiving a full dose/a drop of FLUBLOK came out before or after the needle was pulled out with no reported adverse event; Initial information received on 16-Oct-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age male patient who did not receiving a full dose of Influenza Trivalent Recombinant Vaccine [Flublok] due to a drop of vaccine came out before or after the needle was pulled out with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Influenza Trivalent Recombinant Vaccine, Solution for injection,(unknown strength and expiry date) lot number not reported via unknown route in unknown administration site for influenza immunisation, but a drop of vaccine came out before or after the needle was pulled out with no reported adverse event (incorrect dose administered) (latency same day). It was reported, "Patient said that they were not able to get the full dose and wanted to get another dose". Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.